Case Report: Multidisciplinary management of primary inferior vena cava leiomyosarcoma: a comprehensive case study

Front Oncol. 2023 Nov 13:13:1190276. doi: 10.3389/fonc.2023.1190276. eCollection 2023.

Abstract

Introduction: Primary Inferior vena cava (IVC) leiomyosarcoma, a rare malignant tumor, presents unique challenges in diagnosis and treatment due to its rarity and the lack of consensus on surgical and adjuvant therapy approaches.

Case report: A 39-year-old female patient presented with lower limb swelling and mild fatigue. Contrast-enhanced CT identified a tumor mass within the dilated IVC. Abdominal MRI revealed primary IVC leiomyosarcoma extending into the right hepatic vein. A multidisciplinary consultation established a diagnosis and devised a treatment plan, opting for Ex-vivo Liver Resection and Auto-transplantation (ELRA), tumor resection and IVC reconstruction. Pathological examination confirmed primary IVC leiomyosarcoma. Postoperatively, the patient underwent a comprehensive treatment strategy that included radiochemotherapy, immunotherapy, targeted therapy, and PRaG therapy (PD-1 inhibitor, Radiotherapy, and Granulocyte-macrophage colony-stimulating factor). Despite the tumor's recurrence and metastasis, the disease progression was partially controlled.

Conclusion: This case report emphasizes the complexities of diagnosing and treating IVC leiomyosarcoma and highlights the potential benefits of employing ELRA, IVC reconstruction, and PRaG therapy. Our study may serve as a valuable reference for future investigations addressing the management of this rare disease.

Keywords: adjuvant therapy; case report; inferior vena cava; leiomyosarcoma; surgical resection.

Publication types

  • Case Reports

Grants and funding

This work was supported by the National Natural Science Foundation of China (No.81960314, No.82160349), the Science and Technology Foundation of Guizhou Province (QKHZC[2019]2810, QKHPTRC[2019]5803).